FOLR1, folate receptor alpha, 2348

N. diseases: 174; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027404
Disease: Narcolepsy
Narcolepsy
0.100 GeneticVariation disease GWASDB Genome-wide association database developed in the Japanese Integrated Database Project. 19629137 2009
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN We present the cases of two sisters with cerebral folate transport deficiency caused by mutation in the folate receptor 1 (FOLR1) gene (MIM *136430). 27328863 2016
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Thus, our studies suggest that different clinical severities do not necessarily correlate with residual function of folate receptor alpha mutants and indicate that additional factors contribute to the clinical phenotype in cerebral folate transport deficiency. 22586289 2012
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN (1,3,5,6) We present the late diagnosis of adult siblings with cerebral folate deficiency due to FOLR1 mutations and their subsequent treatment. 27066576 2016
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Delayed myelination and cerebellar atrophy on cranial MRI were important clues to the diagnosis of cerebral folate transport deficiency, which was confirmed by homozygosity for the known nonsense mutation p.R204X in the FOLR1 gene. 24556562 2014
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Diagnosis and management of cerebral folate deficiency. A form of folinic acid-responsive seizures. 25274592 2014
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation. 28255006 2017
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN We report a case of cerebral folate transport deficiency due to a novel homozygous mutation in the FOLR1 gene, in an effort to clarify phenotype-genotype correlation in this newly identified neurometabolic disorder. 20857335 2010
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. 19732866 2009
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood. 24091540 2013
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Pyridoxal phosphate-responsive seizures in a patient with cerebral folate deficiency (CFD) and congenital deafness with labyrinthine aplasia, microtia and microdontia (LAMM). 21752681 2011
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype CLINGEN Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. 10508523 1999
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND Adjusting risk factors in spontaneous abortion by multiple logistic regression. 2044715 1991
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. 19732866 2009
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND We report a case of cerebral folate transport deficiency due to a novel homozygous mutation in the FOLR1 gene, in an effort to clarify phenotype-genotype correlation in this newly identified neurometabolic disorder. 20857335 2010
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND We present the cases of two sisters with cerebral folate transport deficiency caused by mutation in the folate receptor 1 (FOLR1) gene (MIM *136430). 27328863 2016
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND Neuroferritinopathy in a French family with late onset dominant dystonia. 12746423 2003
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders. 27830117 2016
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study. 25046240 2015
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 Biomarker phenotype GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
CUI: C0036572
Disease: Seizures
Seizures
0.400 Biomarker phenotype GENOMICS_ENGLAND Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study. 25046240 2015
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.300 Biomarker disease PSYGENET Such findings highlight the role of downregulation of RFC and FBP expression and provide mechanistic insight into the observed reduced folate transport efficiency at renal absorptive surfaces in alcoholism, which may result in low blood folate levels commonly observed in alcoholics. 18008023 2007
Neurodegeneration Due To Cerebral Folate Transport Deficiency
0.790 GermlineCausalMutation phenotype ORPHANET Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. 19732866 2009
CUI: C0036572
Disease: Seizures
Seizures
0.400 Biomarker phenotype HPO
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.400 Biomarker group HPO